• Jessica Colarossi

    Science Writer Twitter Profile

    Jessica Colarossi

    Jessica Colarossi is a science writer for The Brink. She graduated with a BS in journalism from Emerson College in 2016, with focuses on environmental studies and publishing. While a student, she interned at ThinkProgress in Washington, D.C., where she wrote over 30 stories, most of them relating to climate change, coral reefs, and women’s health. Profile

Comments & Discussion

Boston University moderates comments to facilitate an informed, substantive, civil conversation. Abusive, profane, self-promotional, misleading, incoherent or off-topic comments will be rejected. Moderators are staffed during regular business hours (EST) and can only accept comments written in English. Statistics or facts must include a citation or a link to the citation.

There are 2 comments on Malaria Vaccine—the First Ever to Immunize against a Parasitic Infection—Gets Green Light from WHO

  1. Thanks so much Prof. Hamer for clarifying the complex issues here. Your experience is a major contribution, as are your cautionary notes. I do wonder if the WHO has acted prematurely or at least the media has done so. Those trials are promising, though the multiple doses will be a challenge to deliver in places where there is instability or even local anti-vaccs movements, as with polio, or even smallpox in the day. Malaria loves instability, political, economic, or ideological. New detection tests are an important element here., but they depend on local health insfrastructure. What strain of malaria in a local outbreak would determine whether COARTIM or chloroquine will be effective. How about in Niger, Mali, northern Kenya, southern Sudan, etc where different vectors have spread and health stations are stressed. Malaria loves those conditions.

    This is promising and Dr. Tedros at WHO is a respected malariologist. But WHO in under some pressure to advocate a solution to this global issue, given the kufuffles around COVID. Eradication? or really just control in particular sites? Both the parasites and the vector (mosquito types) are clever and often more adaptive than human responses.

    Let’s hope for better outcomes. And thanks to Dr. Hamer for his excellent work!

  2. Thank you Prof. Hamer for the insightful information. I hope it certainly helps in understand the topics easily in the public. Malaria is a major health issue which needs to controlled to ensure public health. No Malaria Kenya (NoMAK) also gelps reduce the incidence and effects of malaria in Kenya and Africa. More can be found at https://www.nomalaria.com/

Post a comment.

Your email address will not be published. Required fields are marked *